Pneumocystis carinii pneumonia (PCP) is a highly frequent cause of mor
bidity and mortality in immunocompromised subjects, particularly in HI
V-infected ones. The biology of P. carinii is poorly understood becaus
e of the lack of reliable synthetic media or adequate cell lines to gr
ow this opportunistic pathogen in continuous culture. We reported the
suitability of the MDCK (Madin Darby Canine Kidney, ATTC CCL 34) cell
line to support the temporary microorganism's growth in vitro and the
experimental pharmacological trials, in comparison with the HEL 299 ce
ll line, used as reference standard.